Phase II Study of Durvalumab(MEDI4736) + Tremelimumab in Pulmonary Sarcomatoid Carcinoma
Clinical trial NCT06446570 · COMPLETED
Trial details
- NCT number
- NCT06446570
- Sponsor
- Seoul National University Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-10
- Primary completion
- 2019-02-22
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.